CD8A and neoplasm: Upon activation by IL-12, ILC3s, expressing various chemokine receptors, can potentially inhibit tumor growth by recruiting numerous immune cells such as CD8+ T cells, activated MDSC, NK cells, and natural killer T (NKT) cells.